🥳Elections are here at @ASCO! Please vote for @montypal for board of directors! 👏Having worked with Monty for over a decade, alongside countless trainees he has mentored and championed, I can personally attest to his unwavering commitment to our patients, dedication to our field, and exceptional vision for empowering trainees and early-career oncologists across the globe. 🙌Go Monty!! asco.org/election #MedEd #MedX @ASCOTECAG @IMG_Oncologists @HemOncWomenDocs @OncUpdates @oncodaily @OncBrothers @GlopesMd @DrYukselUrun @yekeduz_emre @Latinamd @neerajaiims @HemOncFellows @OncoAlert @DrSAHaddad @CancerNetwrk @Jonathanwlee23 @FLASCO_ORG @ChadTangMD @MVossMD @salvolarosa @GEVaughan1 @Daniel_J_George @brian_rini @Uromigos @LosUromigos @uromigosjapan @DrChoueiri @neerajaiims @PGrivasMDPhD @TDorffOnc @TiansterZhang @DrRanaMcKay @PTarantinoMD @JasmineKambojMD @royaryam @inimfonjackson

Proud to wholeheartedly endorse my dear friend @montypal for the ASCO Board! An exceptional leader, generous mentor, and true champion of women in oncology and young investigators globally! I can think of no one better suited to advance ASCO’s mission globally! Month has been instrumental in guiding me since I started as faculty and I have always benefited from his generosity and kindness personally. You have my vote, Monty! @HemOncWomenDocs @NehaVapiwala @crisbergerot @OncoAlert @NazliDizman @DrChoueiri @neerajaiims @PGrivasMDPhD @TDorffOnc @TiansterZhang @DrRanaMcKay @JasmineKambojMD @AshleySumrallMD @IbiayiMD

So delighted to see my dear friend @PGrivasMDPhD running for the ASCO Nominating Committee! Anyone who knows Petros can attest that he is an energetic, passionate, and dedicated leader who cares about advancing cancer care. And a wonderful human being! ASCO would be fortunate to have his leadership! Please vote asco.org/about-asco/asco-ove… @DrOmarMian @AndreaNecchi @UroDocAsh @TiansterZhang @neerajaiims @montypal @SpiessPhilippe @koshkin85 @jrgralow

Another fantastic initiative by @IMG_Oncologists - how to get involved in clinical trials. The co-operative groups are a welcoming forum for investigators across diverse institutions!

Don’t miss this !! @IMG_Oncologists @GIcancerDoc @montypal @royaryam #SarahPramji @ASCO @OncoAlert

Absolutely no surprise here! 🎉👏 So well deserved @brian_rini & @tompowles1 A huge fan of @Uromigos and the brilliant Tom and Brian❤️ Their passion, wit, and ability to bring the global GU oncology community together for insightful, engaging, and entertaining conversations make this podcast truly special and unique with a 🌏 footprint! Congratulations on this wonderful recognition! 🎙️🏆 @LosUromigos @uromigosjapan @OncoAlert @montypal @neerajaiims @Silke_Gillessen @PGrivasMDPhD @DrChoueiri @ChrisSweens1 @kalasri3 @myESMO @UroDocAsh

Congratulations to our team @ASPIRE_CoP for starting this special interest group @sitcancer See our latest newsletter to learn about the upcoming get together at the annual @sitcancer meeting

At the New England Epic Collaborative Conference, I presented on our team leading the development of IOTOX order sets @umassmemorial. Drawing on @ASPIRE_CoP , we embedded education at the point of care—turning clinical workflows into learning opportunities. @VKazakovaMD

Fantastic fall 2026 @eaonc meeting! Great to connect with colleagues nationwide and brainstorm on concepts in development. Honored to take on a leadership role within the Kidney Cancer Subcommittee as Chair for community - helping broaden access to kidney cancer research.

Really enjoyed the ECOG-ACRIN Fall Meeting! Great to catch up with colleagues, meet new collaborators, and talk through ideas for moving our trials forward. Thanks to everyone who helped put together such a worthwhile meeting!

Here at the fall ECOG meeting with Dr Fitzgerald- our outstanding Radiation Oncology Chair at @umassmemorial His vision and leadership are helping bring proton beam therapy to Central MA. An exciting step toward cancer care closer to home! @UMassCancerCtr @UMass_Medicine

Now published! Our real-world study of 2,030 matched patients: Radium-223 associated with ⬆️ risks of severe cytopenias than ¹⁷⁷Lu-PSMA-617. Further study of long-term marrow health needed post RLT. @PGrivasMDPhD @UMass_Medicine @MrinalPatnaik sciencedirect.com/science/ar…

Must listen episode on PSMAddition trial @Uromigos @tompowles1 @brian_rini with Dr.RobDreicer

📚 Reading recs from ASPIRE: • First-line FMT for ICI colitis: ~77% improved, symptoms resolved in a median of 1.5 days • Recurrent ICI arthritis: the same infl T cells in first and later flares Links 👉 pubmed.ncbi.nlm.nih.gov/4273… pubmed.ncbi.nlm.nih.gov/4253… #irAE #immunotherapy

🎉 Big news! The new ASPIRE Special Interest Group at #SITC26 holds its first in-person meet-up. 📅 Nov 7, 7:10–7:40 PM at the SITC booth in Phoenix. 🌵 Come connect, share ideas & help build the SIG. Appetizers & drinks on us! 🍽️ #irAE #immunotherapy @KMittalmd @sitcancer

JUST IN: @FDA approves the combo of Lenvatinib+HIF2 inhibitor Belzutifan in advanced clear cell renal cell carcinoma following PD1/L1 inhibitor. Results based on Litespark-011 trial led by @motzermd @DrDanielHeng @SchmidigerManu1 @ASCO @myESMO @AACR @kidneycan @DanaFarber_GU @OncoAlert

“What is the goal for better patient preparation for IO treatments?” Join us at the @ASPIRE_CoP webinar that’s happening now!

ASPIRE, a community of practice of @ASCO is proud to present a virtual webinar on Elevating Patient Voices in the Management of irAEs. Join us today at 4 pm EST for our Quarterly Webinar series with hosts @KMittalmd and @afreenshariffmd 🔗 in flyer ⬇️